Global Radiopharmaceuticals Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2021-2027

Publisher Name :
Date: 19-Jul-2021
No. of pages: 138
Inquire Before Buying

Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.

The major players in global Radiopharmaceuticals market include Bracco Imaging, Bayer, Mallinckrodt, etc. The top 3 players hold over 40% of global market shares. North America and Europe are main markets, they occupy over 70% of the global market. Diagnostic Radioisotopes is the main type, with a share about 90%. Oncology is the key application, which hold over 60% shares.

Market Analysis and Insights: Global Radiopharmaceuticals Market

In 2020, the global Radiopharmaceuticals market size was US$ 6260.1 million and it is expected to reach US$ 10730 million by the end of 2027, with a CAGR of 8.0% during 2021-2027.

Global Radiopharmaceuticals Scope and Market Size

Radiopharmaceuticals market is segmented by region, by country, company, type, application and by sales channels. Players, stakeholders, and other participants in the global Radiopharmaceuticals market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region, by country, company, type, application and by sales channels for the period 2016-2027.

Segment by Type, the Radiopharmaceuticals market is segmented into

- Diagnostic Radioisotopes

- Therapeutic Radioisotopes

Segment by Application, the Radiopharmaceuticals market is segmented into

- Oncology

- Cardiology

- Other

Regional and Country-level Analysis:

- North America

- - United States

- - Canada

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Southeast Asia

- - Australia

- - Rest of Asia-Pacific

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- - Nordic Countries

- - Rest of Europe

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

Competitive Landscape and Radiopharmaceuticals Market Share Analysis

Radiopharmaceuticals market competitive landscape provides details and data information by companies. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2016-2021. It also offers detailed analysis supported by reliable statistics on sale and revenue by players for the period 2016-2021. Details included are company description, major business, Radiopharmaceuticals product introduction, recent developments, Radiopharmaceuticals sales by region, type, application and by sales channel.

The major companies include:

- Bracco Imaging

- Bayer

- Mallinckrodt

- Nordion

- Triad Isotopes

- Lantheus

- IBA Group

- GE Healthcare

- China Isotope & Radiation

- Jubilant Pharma

- Eli Lilly

- Advanced Accelerator Applications

- SIEMENS

- Dongcheng

- Navidea

Global Radiopharmaceuticals Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2021-2027

Table of Contents
1 Study Coverage
1.1 Radiopharmaceuticals Product Introduction
1.2 Market by Type
1.2.1 Global Radiopharmaceuticals Market Size Growth Rate by Type
1.2.2 Diagnostic Radioisotopes
1.2.3 Therapeutic Radioisotopes
1.3 Market by Application
1.3.1 Global Radiopharmaceuticals Market Size Growth Rate by Application
1.3.2 Oncology
1.3.3 Cardiology
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Radiopharmaceuticals Market Size Estimates and Forecasts
2.1.1 Global Radiopharmaceuticals Revenue 2016-2027
2.1.2 Global Radiopharmaceuticals Sales 2016-2027
2.2 Radiopharmaceuticals Market Size by Region: 2021 Versus 2027
2.3 Radiopharmaceuticals Sales by Region (2016-2027)
2.3.1 Global Radiopharmaceuticals Sales by Region: 2016-2021
2.3.2 Global Radiopharmaceuticals Sales Forecast by Region (2022-2027)
2.3.3 Global Radiopharmaceuticals Sales Market Share by Region (2016-2027)
2.4 Radiopharmaceuticals Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Radiopharmaceuticals Revenue by Region: 2016-2021
2.4.2 Global Radiopharmaceuticals Revenue Forecast by Region (2022-2027)
2.4.3 Global Radiopharmaceuticals Revenue Market Share by Region (2016-2027)
3 Global Radiopharmaceuticals by Manufacturers
3.1 Global Top Radiopharmaceuticals Manufacturers by Sales
3.1.1 Global Radiopharmaceuticals Sales by Manufacturer (2016-2021)
3.1.2 Global Radiopharmaceuticals Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Radiopharmaceuticals Manufacturers by Revenue
3.2.1 Global Radiopharmaceuticals Revenue by Manufacturer (2016-2021)
3.2.2 Global Radiopharmaceuticals Revenue Share by Manufacturer (2016-2021)
3.3 Global Radiopharmaceuticals Price by Manufacturer (2016-2021)
3.4 Competitive Landscape
3.4.1 Key Radiopharmaceuticals Manufacturers Covered: Ranking by Revenue
3.4.2 Global Radiopharmaceuticals Market Concentration Ratio (CR5 and HHI) & (2016-2021)
3.4.3 Global Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.5 Global Radiopharmaceuticals Manufacturing Base Distribution, Product Type
3.5.1 Radiopharmaceuticals Manufacturers Manufacturing Base Distribution, Headquarters
3.5.2 Manufacturers Radiopharmaceuticals Product Type
3.5.3 Date of International Manufacturers Enter into Radiopharmaceuticals Market
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Company Profiles
4.1 Bracco Imaging
4.1.1 Bracco Imaging Corporation Information
4.1.2 Bracco Imaging Description, Business Overview
4.1.3 Bracco Imaging Radiopharmaceuticals Products Offered
4.1.4 Bracco Imaging Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
4.1.5 Bracco Imaging Radiopharmaceuticals Revenue by Product
4.1.6 Bracco Imaging Radiopharmaceuticals Revenue by Application
4.1.7 Bracco Imaging Radiopharmaceuticals Revenue by Geographic Area
4.1.8 Bracco Imaging Radiopharmaceuticals Revenue by Sales Channel
4.1.9 Bracco Imaging Recent Development
4.2 Bayer
4.2.1 Bayer Corporation Information
4.2.2 Bayer Description, Business Overview
4.2.3 Bayer Radiopharmaceuticals Products Offered
4.2.4 Bayer Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
4.2.5 Bayer Radiopharmaceuticals Revenue by Product
4.2.6 Bayer Radiopharmaceuticals Revenue by Application
4.2.7 Bayer Radiopharmaceuticals Revenue by Geographic Area
4.2.8 Bayer Radiopharmaceuticals Revenue by Sales Channel
4.2.9 Bayer Recent Development
4.3 Mallinckrodt
4.3.1 Mallinckrodt Corporation Information
4.3.2 Mallinckrodt Description, Business Overview
4.3.3 Mallinckrodt Radiopharmaceuticals Products Offered
4.3.4 Mallinckrodt Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
4.3.5 Mallinckrodt Radiopharmaceuticals Revenue by Product
4.3.6 Mallinckrodt Radiopharmaceuticals Revenue by Application
4.3.7 Mallinckrodt Radiopharmaceuticals Revenue by Geographic Area
4.3.8 Mallinckrodt Radiopharmaceuticals Revenue by Sales Channel
4.3.9 Mallinckrodt Recent Development
4.4 Nordion
4.4.1 Nordion Corporation Information
4.4.2 Nordion Description, Business Overview
4.4.3 Nordion Radiopharmaceuticals Products Offered
4.4.4 Nordion Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
4.4.5 Nordion Radiopharmaceuticals Revenue by Product
4.4.6 Nordion Radiopharmaceuticals Revenue by Application
4.4.7 Nordion Radiopharmaceuticals Revenue by Geographic Area
4.4.8 Nordion Radiopharmaceuticals Revenue by Sales Channel
4.4.9 Nordion Recent Development
4.5 Triad Isotopes
4.5.1 Triad Isotopes Corporation Information
4.5.2 Triad Isotopes Description, Business Overview
4.5.3 Triad Isotopes Radiopharmaceuticals Products Offered
4.5.4 Triad Isotopes Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
4.5.5 Triad Isotopes Radiopharmaceuticals Revenue by Product
4.5.6 Triad Isotopes Radiopharmaceuticals Revenue by Application
4.5.7 Triad Isotopes Radiopharmaceuticals Revenue by Geographic Area
4.5.8 Triad Isotopes Radiopharmaceuticals Revenue by Sales Channel
4.5.9 Triad Isotopes Recent Development
4.6 Lantheus
4.6.1 Lantheus Corporation Information
4.6.2 Lantheus Description, Business Overview
4.6.3 Lantheus Radiopharmaceuticals Products Offered
4.6.4 Lantheus Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
4.6.5 Lantheus Radiopharmaceuticals Revenue by Product
4.6.6 Lantheus Radiopharmaceuticals Revenue by Application
4.6.7 Lantheus Radiopharmaceuticals Revenue by Geographic Area
4.6.8 Lantheus Recent Development
4.7 IBA Group
4.7.1 IBA Group Corporation Information
4.7.2 IBA Group Description, Business Overview
4.7.3 IBA Group Radiopharmaceuticals Products Offered
4.7.4 IBA Group Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
4.7.5 IBA Group Radiopharmaceuticals Revenue by Product
4.7.6 IBA Group Radiopharmaceuticals Revenue by Application
4.7.7 IBA Group Radiopharmaceuticals Revenue by Geographic Area
4.7.8 IBA Group Recent Development
4.8 GE Healthcare
4.8.1 GE Healthcare Corporation Information
4.8.2 GE Healthcare Description, Business Overview
4.8.3 GE Healthcare Radiopharmaceuticals Products Offered
4.8.4 GE Healthcare Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
4.8.5 GE Healthcare Radiopharmaceuticals Revenue by Product
4.8.6 GE Healthcare Radiopharmaceuticals Revenue by Application
4.8.7 GE Healthcare Radiopharmaceuticals Revenue by Geographic Area
4.8.8 GE Healthcare Recent Development
4.9 China Isotope & Radiation
4.9.1 China Isotope & Radiation Corporation Information
4.9.2 China Isotope & Radiation Description, Business Overview
4.9.3 China Isotope & Radiation Radiopharmaceuticals Products Offered
4.9.4 China Isotope & Radiation Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
4.9.5 China Isotope & Radiation Radiopharmaceuticals Revenue by Product
4.9.6 China Isotope & Radiation Radiopharmaceuticals Revenue by Application
4.9.7 China Isotope & Radiation Radiopharmaceuticals Revenue by Geographic Area
4.9.8 China Isotope & Radiation Recent Development
4.10 Jubilant Pharma
4.10.1 Jubilant Pharma Corporation Information
4.10.2 Jubilant Pharma Description, Business Overview
4.10.3 Jubilant Pharma Radiopharmaceuticals Products Offered
4.10.4 Jubilant Pharma Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
4.10.5 Jubilant Pharma Radiopharmaceuticals Revenue by Product
4.10.6 Jubilant Pharma Radiopharmaceuticals Revenue by Application
4.10.7 Jubilant Pharma Radiopharmaceuticals Revenue by Geographic Area
4.10.8 Jubilant Pharma Recent Development
4.11 Eli Lilly
4.11.1 Eli Lilly Corporation Information
4.11.2 Eli Lilly Description, Business Overview
4.11.3 Eli Lilly Radiopharmaceuticals Products Offered
4.11.4 Eli Lilly Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
4.11.5 Eli Lilly Radiopharmaceuticals Revenue by Product
4.11.6 Eli Lilly Radiopharmaceuticals Revenue by Application
4.11.7 Eli Lilly Radiopharmaceuticals Revenue by Geographic Area
4.11.8 Eli Lilly Recent Development
4.12 Advanced Accelerator Applications
4.12.1 Advanced Accelerator Applications Corporation Information
4.12.2 Advanced Accelerator Applications Description, Business Overview
4.12.3 Advanced Accelerator Applications Radiopharmaceuticals Products Offered
4.12.4 Advanced Accelerator Applications Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
4.12.5 Advanced Accelerator Applications Radiopharmaceuticals Revenue by Product
4.12.6 Advanced Accelerator Applications Radiopharmaceuticals Revenue by Application
4.12.7 Advanced Accelerator Applications Radiopharmaceuticals Revenue by Geographic Area
4.12.8 Advanced Accelerator Applications Recent Development
4.13 SIEMENS
4.13.1 SIEMENS Corporation Information
4.13.2 SIEMENS Description, Business Overview
4.13.3 SIEMENS Radiopharmaceuticals Products Offered
4.13.4 SIEMENS Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
4.13.5 SIEMENS Radiopharmaceuticals Revenue by Product
4.13.6 SIEMENS Radiopharmaceuticals Revenue by Application
4.13.7 SIEMENS Radiopharmaceuticals Revenue by Geographic Area
4.13.8 SIEMENS Recent Development
4.14 Dongcheng
4.14.1 Dongcheng Corporation Information
4.14.2 Dongcheng Description, Business Overview
4.14.3 Dongcheng Radiopharmaceuticals Products Offered
4.14.4 Dongcheng Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
4.14.5 Dongcheng Radiopharmaceuticals Revenue by Product
4.14.6 Dongcheng Radiopharmaceuticals Revenue by Application
4.14.7 Dongcheng Radiopharmaceuticals Revenue by Geographic Area
4.14.8 Dongcheng Recent Development
4.15 Navidea
4.15.1 Navidea Corporation Information
4.15.2 Navidea Description, Business Overview
4.15.3 Navidea Radiopharmaceuticals Products Offered
4.15.4 Navidea Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
4.15.5 Navidea Radiopharmaceuticals Revenue by Product
4.15.6 Navidea Radiopharmaceuticals Revenue by Application
4.15.7 Navidea Radiopharmaceuticals Revenue by Geographic Area
4.15.8 Navidea Recent Development
5 Breakdown Data by Type
5.1 Global Radiopharmaceuticals Sales by Type (2016-2027)
5.1.1 Global Radiopharmaceuticals Sales by Type (2016-2021)
5.1.2 Global Radiopharmaceuticals Sales Forecast by Type (2022-2027)
5.1.3 Global Radiopharmaceuticals Sales Market Share by Type (2016-2027)
5.2 Global Radiopharmaceuticals Revenue Forecast by Type (2016-2027)
5.2.1 Global Radiopharmaceuticals Revenue by Type (2016-2021)
5.2.2 Global Radiopharmaceuticals Revenue Forecast by Type (2022-2027)
5.2.3 Global Radiopharmaceuticals Revenue Market Share by Type (2016-2027)
5.3 Radiopharmaceuticals Average Selling Price (ASP) by Type (2016-2027)
6 Breakdown Data by Application
6.1 Global Radiopharmaceuticals Sales by Application (2016-2027)
6.1.1 Global Radiopharmaceuticals Sales by Application (2016-2021)
6.1.2 Global Radiopharmaceuticals Sales Forecast by Application (2022-2027)
6.1.3 Global Radiopharmaceuticals Sales Market Share by Application (2016-2027)
6.2 Global Radiopharmaceuticals Revenue Forecast by Application (2016-2027)
6.2.1 Global Radiopharmaceuticals Revenue by Application (2016-2021)
6.2.2 Global Radiopharmaceuticals Revenue Forecast by Application (2022-2027)
6.2.3 Global Radiopharmaceuticals Revenue Market Share by Application (2016-2027)
6.3 Radiopharmaceuticals Average Selling Price (ASP) by Application (2016-2027)
7 North America
7.1 North America Radiopharmaceuticals Market Size YoY Growth 2016-2027
7.2 North America Radiopharmaceuticals Market Facts & Figures by Country
7.2.1 North America Radiopharmaceuticals Sales by Country (2016-2027)
7.2.2 North America Radiopharmaceuticals Revenue by Country (2016-2027)
7.3 North America Radiopharmaceuticals Sales by Type
7.4 North America Radiopharmaceuticals Sales by Application
8 Asia-Pacific
8.1 Asia-Pacific Radiopharmaceuticals Market Size YoY Growth 2016-2027
8.2 Asia-Pacific Radiopharmaceuticals Market Facts & Figures by Region
8.2.1 Asia-Pacific Radiopharmaceuticals Sales by Region (2016-2027)
8.2.2 Asia-Pacific Radiopharmaceuticals Revenue by Region (2016-2027)
8.3 Asia-Pacific Radiopharmaceuticals Sales by Type
8.4 Asia-Pacific Radiopharmaceuticals Sales by Application
9 Europe
9.1 Europe Radiopharmaceuticals Market Size YoY Growth 2016-2027
9.2 Europe Radiopharmaceuticals Market Facts & Figures by Country
9.2.1 Europe Radiopharmaceuticals Sales by Country (2016-2027)
9.2.2 Europe Radiopharmaceuticals Revenue by Country (2016-2027)
9.3 Europe Radiopharmaceuticals Sales by Type
9.4 Europe Radiopharmaceuticals Sales by Application
10 Latin America
10.1 Latin America Radiopharmaceuticals Market Size YoY Growth 2016-2027
10.2 Latin America Radiopharmaceuticals Market Facts & Figures by Country
10.2.1 Latin America Radiopharmaceuticals Sales by Country (2016-2027)
10.2.2 Latin America Radiopharmaceuticals Revenue by Country (2016-2027)
10.3 Latin America Radiopharmaceuticals Sales by Type
10.4 Latin America Radiopharmaceuticals Sales by Application
11 Middle East and Africa
11.1 Middle East and Africa Radiopharmaceuticals Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Radiopharmaceuticals Market Facts & Figures by Country
11.2.1 Middle East and Africa Radiopharmaceuticals Sales by Country (2016-2027)
11.2.2 Middle East and Africa Radiopharmaceuticals Revenue by Country (2016-2027)
11.3 Middle East and Africa Radiopharmaceuticals Sales by Type
11.4 Middle East and Africa Radiopharmaceuticals Sales by Application
12 Supply Chain and Sales Channel Analysis
12.1 Radiopharmaceuticals Supply Chain Analysis
12.2 Radiopharmaceuticals Key Raw Materials and Upstream Suppliers
12.3 Radiopharmaceuticals Clients Analysis
12.4 Radiopharmaceuticals Sales Channel and Sales Model Analysis
12.4.1 Radiopharmaceuticals Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Radiopharmaceuticals Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Radiopharmaceuticals Distributors
13 Market Dynamics
13.1 Radiopharmaceuticals Market Drivers
13.2 Radiopharmaceuticals Market Opportunities
13.3 Radiopharmaceuticals Market Challenges
13.4 Radiopharmaceuticals Market Restraints
13.5 Porter's Five Forces Analysis
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Radiopharmaceuticals Market Size Growth Rate by Type (US$ Million): 2021 VS 2027
Table 2. Major Manufacturers of Diagnostic Radioisotopes
Table 3. Major Manufacturers of Therapeutic Radioisotopes
Table 4. Global Radiopharmaceuticals Market Size Growth by Application (US$ Million): 2021 VS 2027
Table 5. Global Radiopharmaceuticals Market Size by Region (US$ Million): 2021 VS 2027
Table 6. Global Radiopharmaceuticals Sales by Region (2016-2021) & (K Dose)
Table 7. Global Radiopharmaceuticals Sales Forecast by Region (2022-2027) & (K Dose)
Table 8. Global Radiopharmaceuticals Revenue by Region (2016-2021) & (US$ Million)
Table 9. Global Radiopharmaceuticals Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 10. Global Radiopharmaceuticals Sales by Manufacturer (2016-2021) & (K Dose)
Table 11. Global Radiopharmaceuticals Sales Share by Manufacturer (2016-2021)
Table 12. Radiopharmaceuticals Revenue by Manufacturer (2016-2021) & (US$ Million)
Table 13. Radiopharmaceuticals Revenue Share by Manufacturer (2016-2021)
Table 14. Key Manufacturers Radiopharmaceuticals Price (2016-2021) & (US$/Dose)
Table 15. Ranking of Global Top Radiopharmaceuticals Manufacturers by Revenue (US$ Million) in 2020
Table 16. Global Radiopharmaceuticals Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 17. Global Radiopharmaceuticals by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Radiopharmaceuticals as of 2020)
Table 18. Radiopharmaceuticals Manufacturers Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers Radiopharmaceuticals Product Type
Table 20. Date of International Manufacturers Enter into Radiopharmaceuticals Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Bracco Imaging Corporation Information
Table 23. Bracco Imaging Description and Business Overview
Table 24. Bracco Imaging Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021)
Table 25. Bracco Imaging Radiopharmaceuticals Product
Table 26. Bracco Imaging Radiopharmaceuticals Revenue (US$ Million) and Market Share by Product
Table 27. Bracco Imaging Radiopharmaceuticals Revenue (US$ Million) and Market Share by Application
Table 28. Bracco Imaging Radiopharmaceuticals Revenue (US$ Million) and Market Share by Geographic Area
Table 29. Bracco Imaging Radiopharmaceuticals Revenue (US$ Million) and Market Share by Sales Channel
Table 30. Bracco Imaging Recent Development
Table 31. Bayer Corporation Information
Table 32. Bayer Description and Business Overview
Table 33. Bayer Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021)
Table 34. Bayer Radiopharmaceuticals Product
Table 35. Bayer Radiopharmaceuticals Revenue (US$ Million) and Market Share by Product
Table 36. Bayer Radiopharmaceuticals Revenue (US$ Million) and Market Share by Application
Table 37. Bayer Radiopharmaceuticals Revenue (US$ Million) and Market Share by Geographic Area
Table 38. Bayer Radiopharmaceuticals Revenue (US$ Million) and Market Share by Sales Channel
Table 39. Bayer Recent Development
Table 40. Mallinckrodt Corporation Information
Table 41. Mallinckrodt Description and Business Overview
Table 42. Mallinckrodt Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021)
Table 43. Mallinckrodt Radiopharmaceuticals Product
Table 44. Mallinckrodt Radiopharmaceuticals Revenue (US$ Million) and Market Share by Product
Table 45. Mallinckrodt Radiopharmaceuticals Revenue (US$ Million) and Market Share by Application
Table 46. Mallinckrodt Radiopharmaceuticals Revenue (US$ Million) and Market Share by Geographic Area
Table 47. Mallinckrodt Radiopharmaceuticals Revenue (US$ Million) and Market Share by Sales Channel
Table 48. Mallinckrodt Recent Development
Table 49. Nordion Corporation Information
Table 50. Nordion Description and Business Overview
Table 51. Nordion Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021)
Table 52. Nordion Radiopharmaceuticals Product
Table 53. Nordion Radiopharmaceuticals Revenue (US$ Million) and Market Share by Product
Table 54. Nordion Radiopharmaceuticals Revenue (US$ Million) and Market Share by Application
Table 55. Nordion Radiopharmaceuticals Revenue (US$ Million) and Market Share by Geographic Area
Table 56. Nordion Radiopharmaceuticals Revenue (US$ Million) and Market Share by Sales Channel
Table 57. Nordion Recent Development
Table 58. Triad Isotopes Corporation Information
Table 59. Triad Isotopes Description and Business Overview
Table 60. Triad Isotopes Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021)
Table 61. Triad Isotopes Radiopharmaceuticals Product
Table 62. Triad Isotopes Radiopharmaceuticals Revenue (US$ Million) and Market Share by Product
Table 63. Triad Isotopes Radiopharmaceuticals Revenue (US$ Million) and Market Share by Application
Table 64. Triad Isotopes Radiopharmaceuticals Revenue (US$ Million) and Market Share by Geographic Area
Table 65. Triad Isotopes Radiopharmaceuticals Revenue (US$ Million) and Market Share by Sales Channel
Table 66. Triad Isotopes Recent Development
Table 67. Lantheus Corporation Information
Table 68. Lantheus Description and Business Overview
Table 69. Lantheus Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021)
Table 70. Lantheus Radiopharmaceuticals Product
Table 71. Lantheus Radiopharmaceuticals Revenue (US$ Million) and Market Share by Product
Table 72. Lantheus Radiopharmaceuticals Revenue (US$ Million) and Market Share by Application
Table 73. Lantheus Radiopharmaceuticals Revenue (US$ Million) and Market Share by Geographic Area
Table 74. Lantheus Recent Development
Table 75. IBA Group Corporation Information
Table 76. IBA Group Description and Business Overview
Table 77. IBA Group Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021)
Table 78. IBA Group Radiopharmaceuticals Product
Table 79. IBA Group Radiopharmaceuticals Revenue (US$ Million) and Market Share by Product
Table 80. IBA Group Radiopharmaceuticals Revenue (US$ Million) and Market Share by Application
Table 81. IBA Group Radiopharmaceuticals Revenue (US$ Million) and Market Share by Geographic Area
Table 82. IBA Group Recent Development
Table 83. GE Healthcare Corporation Information
Table 84. GE Healthcare Description and Business Overview
Table 85. GE Healthcare Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021)
Table 86. GE Healthcare Radiopharmaceuticals Product
Table 87. GE Healthcare Radiopharmaceuticals Revenue (US$ Million) and Market Share by Product
Table 88. GE Healthcare Radiopharmaceuticals Revenue (US$ Million) and Market Share by Application
Table 89. GE Healthcare Radiopharmaceuticals Revenue (US$ Million) and Market Share by Geographic Area
Table 90. GE Healthcare Recent Development
Table 91. China Isotope & Radiation Corporation Information
Table 92. China Isotope & Radiation Description and Business Overview
Table 93. China Isotope & Radiation Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021)
Table 94. China Isotope & Radiation Radiopharmaceuticals Product
Table 95. China Isotope & Radiation Radiopharmaceuticals Revenue (US$ Million) and Market Share by Product
Table 96. China Isotope & Radiation Radiopharmaceuticals Revenue (US$ Million) and Market Share by Application
Table 97. China Isotope & Radiation Radiopharmaceuticals Revenue (US$ Million) and Market Share by Geographic Area
Table 98. China Isotope & Radiation Recent Development
Table 99. Jubilant Pharma Corporation Information
Table 100. Jubilant Pharma Description and Business Overview
Table 101. Jubilant Pharma Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021)
Table 102. Jubilant Pharma Radiopharmaceuticals Product
Table 103. Jubilant Pharma Radiopharmaceuticals Revenue (US$ Million) and Market Share by Product
Table 104. Jubilant Pharma Radiopharmaceuticals Revenue (US$ Million) and Market Share by Application
Table 105. Jubilant Pharma Radiopharmaceuticals Revenue (US$ Million) and Market Share by Geographic Area
Table 106. Jubilant Pharma Recent Development
Table 107. Eli Lilly Corporation Information
Table 108. Eli Lilly Description and Business Overview
Table 109. Eli Lilly Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021)
Table 110. Eli Lilly Radiopharmaceuticals Product
Table 111. Eli Lilly Radiopharmaceuticals Revenue (US$ Million) and Market Share by Product
Table 112. Eli Lilly Radiopharmaceuticals Revenue (US$ Million) and Market Share by Application
Table 113. Eli Lilly Radiopharmaceuticals Revenue (US$ Million) and Market Share by Geographic Area
Table 114. Eli Lilly Recent Development
Table 115. Advanced Accelerator Applications Corporation Information
Table 116. Advanced Accelerator Applications Description and Business Overview
Table 117. Advanced Accelerator Applications Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021)
Table 118. Advanced Accelerator Applications Radiopharmaceuticals Product
Table 119. Advanced Accelerator Applications Radiopharmaceuticals Revenue (US$ Million) and Market Share by Product
Table 120. Advanced Accelerator Applications Radiopharmaceuticals Revenue (US$ Million) and Market Share by Application
Table 121. Advanced Accelerator Applications Radiopharmaceuticals Revenue (US$ Million) and Market Share by Geographic Area
Table 122. Advanced Accelerator Applications Recent Development
Table 123. SIEMENS Corporation Information
Table 124. SIEMENS Description and Business Overview
Table 125. SIEMENS Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021)
Table 126. SIEMENS Radiopharmaceuticals Product
Table 127. SIEMENS Radiopharmaceuticals Revenue (US$ Million) and Market Share by Product
Table 128. SIEMENS Radiopharmaceuticals Revenue (US$ Million) and Market Share by Application
Table 129. SIEMENS Radiopharmaceuticals Revenue (US$ Million) and Market Share by Geographic Area
Table 130. SIEMENS Recent Development
Table 131. Dongcheng Corporation Information
Table 132. Dongcheng Description and Business Overview
Table 133. Dongcheng Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021)
Table 134. Dongcheng Radiopharmaceuticals Product
Table 135. Dongcheng Radiopharmaceuticals Revenue (US$ Million) and Market Share by Product
Table 136. Dongcheng Radiopharmaceuticals Revenue (US$ Million) and Market Share by Application
Table 137. Dongcheng Radiopharmaceuticals Revenue (US$ Million) and Market Share by Geographic Area
Table 138. Dongcheng Recent Development
Table 139. Navidea Corporation Information
Table 140. Navidea Description and Business Overview
Table 141. Navidea Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021)
Table 142. Navidea Radiopharmaceuticals Product
Table 143. Navidea Radiopharmaceuticals Revenue (US$ Million) and Market Share by Product
Table 144. Navidea Radiopharmaceuticals Revenue (US$ Million) and Market Share by Application
Table 145. Navidea Radiopharmaceuticals Revenue (US$ Million) and Market Share by Geographic Area
Table 146. Navidea Recent Development
Table 147. Global Radiopharmaceuticals Sales by Type (2016-2021) & (K Dose)
Table 148. Global Radiopharmaceuticals Sales Forecast by Type (2022-2027) & (K Dose)
Table 149. Global Radiopharmaceuticals Revenue by Type (2016-2021) & (US$ Million)
Table 150. Global Radiopharmaceuticals Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 151. Global Radiopharmaceuticals Sales by Application (2016-2021) & (K Dose)
Table 152. Global Radiopharmaceuticals Sales Forecast by Application (2022-2027) & (K Dose)
Table 153. Global Radiopharmaceuticals Revenue by Application (2016-2021) & (US$ Million)
Table 154. Global Radiopharmaceuticals Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 155. North America Radiopharmaceuticals Sales by Country (2016-2021) & (K Dose)
Table 156. North America Radiopharmaceuticals Sales by Country (2022-2027) & (K Dose)
Table 157. North America Radiopharmaceuticals Revenue by Country (2016-2021) & (US$ Million)
Table 158. North America Radiopharmaceuticals Revenue by Country (2022-2027) & (US$ Million)
Table 159. North America Radiopharmaceuticals Sales by Type (2016-2021) & (K Dose)
Table 160. North America Radiopharmaceuticals Sales by Application (2016-2021) & (K Dose)
Table 161. Asia-Pacific Radiopharmaceuticals Sales by Region (2016-2021) & (K Dose)
Table 162. Asia-Pacific Radiopharmaceuticals Sales by Region (2022-2027) & (K Dose)
Table 163. Asia-Pacific Radiopharmaceuticals Revenue by Region (2016-2027) & (US$ Million)
Table 164. Asia-Pacific Radiopharmaceuticals Revenue by Region (2022-2027) & (US$ Million)
Table 165. Asia-Pacific Radiopharmaceuticals Sales by Type (2016-2021) & (K Dose)
Table 166. Asia-Pacific Radiopharmaceuticals Sales by Application (2016-2021) & (K Dose)
Table 167. Europe Radiopharmaceuticals Sales by Country (2016-2021) & (K Dose)
Table 168. Europe Radiopharmaceuticals Sales by Country (2022-2027) & (K Dose)
Table 169. Europe Radiopharmaceuticals Revenue by Country (2016-2021) & (US$ Million)
Table 170. Europe Radiopharmaceuticals Revenue by Country (2022-2027) & (US$ Million)
Table 171. Europe Radiopharmaceuticals Sales by Type (2016-2021) & (K Dose)
Table 172. Europe Radiopharmaceuticals Sales by Application (2016-2021) & (K Dose)
Table 173. Latin America Radiopharmaceuticals Sales by Country (2016-2021) & (K Dose)
Table 174. Latin America Radiopharmaceuticals Sales by Country (2022-2027) & (K Dose)
Table 175. Latin America Radiopharmaceuticals Revenue by Country (2016-2021) & (US$ Million)
Table 176. Latin America Radiopharmaceuticals Revenue by Country (2022-2027) & (US$ Million)
Table 177. Latin America Radiopharmaceuticals Sales by Type (2016-2021) & (K Dose)
Table 178. Latin America Radiopharmaceuticals Sales by Application (2016-2021) & (K Dose)
Table 179. Middle East and Africa Radiopharmaceuticals Sales by Country (2016-2021) & (K Dose)
Table 180. Middle East and Africa Radiopharmaceuticals Sales by Country (2022-2027) & (K Dose)
Table 181. Middle East and Africa Radiopharmaceuticals Revenue by Country (2016-2021) & (US$ Million)
Table 182. Middle East and Africa Radiopharmaceuticals Revenue by Country (2022-2027) & (US$ Million)
Table 183. Middle East and Africa Radiopharmaceuticals Sales by Type (2016-2021) & (K Dose)
Table 184. Middle East and Africa Radiopharmaceuticals Sales by Application (2016-2021) & (K Dose)
Table 185. Radiopharmaceuticals Key Raw Materials, Industry Status and Trend
Table 186. Radiopharmaceuticals Key Raw Materials and Upstream Suppliers
Table 187. Radiopharmaceuticals Clients Status and Trend
Table 188. Radiopharmaceuticals Typical Clients
Table 189. Radiopharmaceuticals Distributors
Table 190. Key Drivers: Impact Analysis (2022-2027)
Table 191. Radiopharmaceuticals Market Drivers
Table 192. Radiopharmaceuticals Marke
  • Global Radiopharmaceuticals Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2021-2027
    Published: 19-Jul-2021        Price: US 5900 Onwards        Pages: 138
    Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for ex......
  • Global Radiopharmaceuticals Market Growth 2021-2026
    Published: 15-Jul-2021        Price: US 3660 Onwards        Pages: 112
    According to this latest study, the 2021 growth of Radiopharmaceuticals will have significant change from previous year. By the most conservative estimates of global Radiopharmaceuticals market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 6123.9 million in 2020. Over the next five years the Radiopharmaceuticals market will register a 8.3% CAGR in terms of revenue, the global market size will reach US$ 8424.2 million by 2026. This......
  • Global Radiation Dose Management Market Size, Status and Forecast 2021-2027
    Published: 12-Jul-2021        Price: US 3900 Onwards        Pages: 108
    Market Analysis and Insights: Global Radiation Dose Management Market The global Radiation Dose Management market size is projected to reach US$ 862.7 million by 2027, from US$ 195.6 million in 2020, at a CAGR of 23.1% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Radiation Dose Management market to help players in achieving a strong market position. Buy......
  • 2021-2030 Report on Global Radiopharmaceutical Market by Player, Region, Type, Application and Sales Channel
    Published: 10-Jul-2021        Price: US 2500 Onwards        Pages: 118
    This report studies the Radiopharmaceutical market, covering market size for segment by type (Actinium-225, Lutetium-177, etc.), by application (Oncology, Cardiology, etc.), by Sales Channel (Direct Channel, Distribution Channel), by player (Bracco Imaging, Bayer, Mallinckrodt, Nordion, Triad Isotopes, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa). Since the pandemic of COVID-19 is still raging, The COVID-19 will have a certain i......
  • Radiopharmaceutical Global Market Insights 2021, Analysis and Forecast to 2026, by Manufacturers, Regions, Technology, Application, Product Type
    Published: 04-Jul-2021        Price: US 3200 Onwards        Pages: 130
    This report describes the global market size of Radiopharmaceutical from 2016 to 2020 and its CAGR from 2016 to 2020, and also forecasts its market size to the end of 2026 and its CAGR from 2021 to 2026. For geography segment, regional supply, demand, major players, price is presented from 2016 to 2026. This report cover following regions: North America South America Asia & Pacific Europe MEA The key countries for each regions are also incl......
  • Global Radiopharmaceutical Market Growth 2021-2026
    Published: 25-Jun-2021        Price: US 3660 Onwards        Pages: 114
    According to this latest study, the 2021 growth of Radiopharmaceutical will have significant change from previous year. By the most conservative estimates of global Radiopharmaceutical market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 6188.4 million in 2020. Over the next five years the Radiopharmaceutical market will register a 8.9% CAGR in terms of revenue, the global market size will reach US$ 8710.2 million by 2026. This re......
  • 2020-2025 Global Radiopharmaceutical Market Report - Production and Consumption Professional Analysis (Impact of COVID-19)
    Published: 17-Jun-2021        Price: US 3360 Onwards        Pages: 103
    This report elaborates the market size, market characteristics, and market growth of the Radiopharmaceutical industry, and breaks down according to the type, application, and consumption area of Radiopharmaceutical. The report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry. In Chapter 3.4 of the report, the impact of the COVID-19 outbreak on the industry was fully assessed. Fully risk assessment and......
  • Global Radiopharmaceuticals Market Insights and Forecast to 2027
    Published: 26-May-2021        Price: US 4900 Onwards        Pages: 146
    Radiopharmaceuticals market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Radiopharmaceuticals market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027. Segment by Type - Diagnostic Radioisotopes - Therapeutic Radioisotopes Segment by Application ......
  • 2020-2025 Global Radiation Dose Management Market Report - Production and Consumption Professional Analysis (Impact of COVID-19)
    Published: 25-May-2021        Price: US 3360 Onwards        Pages: 132
    The radiation dose management channel includes information of radiation dose recording software, real-time staff dose monitoring, regulatory compliance and technology to reduce dose, including interative reconstruction software. This report elaborates the market size, market characteristics, and market growth of the Radiation Dose Management industry, and breaks down according to the type, application, and consumption area of Radiation Dose Management. The report also conducted a PESTEL a......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs